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Clinical Application of 7.0 T Magnetic Resonance Images in 
Gamma Knife Radiosurgery for a Patient with Brain Metastases
In the study we assessed the distortion of 7.0 T magnetic resonance (MR) images in 
reference to 1.5 T MR images in the radiosurgery of metastatic brain tumors. Radiosurgery 
with Gamma Knife Perfexion® was performed for the treatment of a 54-yr-old female 
patient with multiple brain metastases by the co-registered images of the 7.0 T and 1.5 T 
magnetic resonance images (MRI). There was no significant discrepancy in the positions of 
anterior and posterior commissures as well as the locations of four metastatic brain tumors 
in the co-registered images between 7.0 T and 1.5 T MRI with better visualization of the 
anatomical details in 7.0 T MR images. This study demonstrates for the first time that 7.0 T 
MR images can be safely utilized in Perfexion® Gamma Knife radiosurgery for the 
treatment of metastatic brain tumors. Furthermore 7.0 T MR images provide better 
visualization of brain tumors without image distortion in comparison to 1.5 T MR images.  
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CASE REPORT
Neuroscience
INTRODUCTION
Metastatic brain tumor is the most common malignant brain 
tumors. Because of their rapid progression, early detection of 
metastatic brain tumors is essential for the treatment. For the 
early detection of the metastatic brain tumors, high-field mag-
netic resonance (MR) images such as 7.0 T MR images may be 
helpful since smaller tumors can be detected by virtue of higher 
spatial resolution and better visualization of anatomical details 
(1, 2).
  There have been several anecdotal reports of 7.0 T MR imag-
es in a small group of normal subjects or patients with stroke, 
cavernous malformations, or multiple sclerosis (1, 3-10). How-
ever, the report about the use of 7.0 T MR images for brain tu-
mors is limited only to animal model due to technical and safe-
ty issues (11, 12).  
  Hereby we report a case of multiple metastatic brain tumors 
in a patient who was treated by Gamma Knife Perfexion
® (Elek-
ta AB, Stockholm, Sweden) with the co-registered images of the 
7.0 T and 1.5 T MR images. Magnetization Prepared Rapid Ac-
quisition Gradient Echo (MPRAGE) gadolinium-enhanced T1-
weighted MR images of 7.0 T and 1.5 T were fused by using Im-
ageMerge
TM (Elekta AB, Stockholm, Sweden), a fusion software 
program integrated in a treatment planning software, Leksell 
Gamma Plan
® v8.3 (Elekta AB, Stockholm, Sweden). 
CASE DESCRIPTION
A right upper lung mass was detected in the routine examination 
of simple chest radiography of a 56-yr-old woman. Her chest 
computed tomography (CT) scan revealed a 4-cm sized mass 
lesion in the right upper lung field with obstruction of right up-
per lung apical segmental bronchus. Her abdominal CT scan 
revealed a mass at the distal rectum with serosal invasion. A per-
cutaneous needle aspiration biopsy of the right upper lung mass 
was performed. A colonoscopic biopsy of a rectal mass was done. 
Both revealed adenocarcinomas. Her 1.5 T brain MR images 
demonstrated three small mass lesions in her left parieto-tem-
poral lobe. She refused to undergo surgical resection and re-
ceived six cycles of anticancer chemotherapy over six months. 
After completion of chemotherapy, mass lesions in the lung and 
the rectum remained stable. She received Gamma Knife Radio-
surgery (GK RS) for brain metastases on September 1st, 2009. 
  She had taken 7.0 T MR images (Magnetom 7.0 T, Siemens
®) 
one day before GK RS. We received the permission from the Ko-
rean Food and Drug Administration and the Institutional Review 
Board of Seoul National University Hospital and the Neurosci-
ence Research Institute of Gacheon Medical Center (IRB Num-Paek SH, et al.  •  7.0 T MRI in GK Radiosurgery
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ber: 0802-046-234). A written consent was obtained from the pa-
tient. The 7.0 T MR images (Magnetom 7.0 T, Siemens
®) at Neu-
roscience Research Institute of Gacheon University of Medicine 
and Science were used for imaging of the patient. The 7.0 T mag-
net, with a clear bore of 90 cm, is equipped with a water cooled 
gradient and RF coils. The gradient system operates at 2,000 V/ 
650 Amp with gradient amplitude of 40 mT/m, a maximum slew 
rate of 200 mT/m/ms, and a minimum gradient rise time of 200 
microseconds. A birdcage TX/RX single channel coil was used. 
T1-weighted magnetic resonance images (MRI) was scanned 
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Fig. 1. Axial, coronal, and sagittal images of the anterior commissure (   ) and the posterior commissure (∆) in 1.5T and 7.0 T magnetic resonance images (MRI). In the co-
registered images of the 7.0T MRI and 1.5T MRI, there is no significant difference in the location of the AC and PC between 1.5T (A-C) and 7.0T MRI (D-F) whereas enhanced 
anatomical details of the metastatic brain tumors are provided by 7.0T MRI. 
A D C B
E H G F
Fig. 2. Axial images of four metastatic brain tumors in the co-registered images of 1.5 T and 7.0 T magnetic resonance images (MRI). Upper panel shows 1.5 T MRI (A-D) and 
lower panel shows 7.0 T MRI (E-H). Total four metastastic brain tumors are found; three lesions in the left parietal (A, E) and temporal lobe (B, C, F, G) and one in the right side 
of the pons (D, H). Paek SH, et al.  •  7.0 T MRI in GK Radiosurgery
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before and after injection of a contrast agent. The Magnevist 
(Bayer Healthcare Pharmaceuticals Inc., Liverkusen, Germany) 
was used as the contrast agent by 0.2 mL/kg (0.01 mM/kg). Pulse 
sequence used was 3D Magnetization Prepared Rapid Acquisi-
tion Gradient Echo (MPRAGE) and the followings are the scan-
ning parameters: TR = 4,000 ms, TE = 3.92 ms, TI = 1,000 ms, 
Thickness = 0.7 mm, flip angle = 10°, number of slice = 256, vox-
el size = 0.35 × 0.35 × 0.7 mm, and matrix size = 448 × 448.
  GK RS was performed at Seoul National University Hospital. A 
Leksell stereotactic frame G (Elekta AB, Stockholm, Sweden) was 
applied to the patient head under local anesthesia. T1-weight-
ed 3D MPRAGE images were obtained before and after double 
dose gadolinium enhancement using Signa Excite 1.5 T MR 
(General Electric Medical System, Milwaukee, WI, USA). Scan-
ning parameters were: TR = 11.7 ms, TE = 5.2 ms, thickness = 1.5 
mm, voxel size = 0.94 × 0.94 × 1.5 mm and matrix size = 256 × 256. 
  Total four metastastic brain tumors were found; two lesions 
in the left parietal lobe and one in temporal lobe, and one in the 
right side of the pons. The measured tumor volume were 0.096 
mL, 0.079 mL, 0.0314 mL, and 0.0062 mL which were treated with 
22 Gy, 22 Gy, 22 Gy, and 20 Gy at the 50% isodose line, respec-
tively. 
  7.0 T axial images were co-registered to 1.5 T axial images us-
ing a commercial software, ImageMerge
TM (Elekta AB, Stock-
holm, Sweden), which was integrated into a treatment planning 
software, Leksell Gamma Plan
® v8.3 (Elekta AB, Stockholm, 
Sweden). Co-registration was automatically performed by an 
algorithm based on the mutual information method. Locations 
of AC and PC, and tumor volumes were measured five times 
with Leksell Gamma Plan
® v8.3 (Elekta AB, Stockholm, Sweden) 
in both image sets and compared. 
  We found that in the co-registered images of the 7.0 T MR im-
ages and 1.5 T MR images, there was no significant discrepancy 
of the location of the AC and PC as well as the locations of four 
metastatic brain tumors. Images of the 7.0 T and 1.5 T MPRAGE 
gadolinium-enhanced T1-weighted MRI are co-registered by 
using ImageMerge
TM (Elekta AB, Stockholm, Sweden), a fusion 
software program integrated in a treatment planning software, 
Leksell Gamma Plan
® v8.3 (Elekta AB, Stockholm, Sweden) (Fig. 
1). All images were realigned to midsagittal AC-PC line. In the 
co-registered images of the 7.0 T MRI and 1.5 T MRI, there was 
no significant difference in the location of the AC and PC be-
tween 1.5 T (Fig. 1A-C) and 7.0 T MRI (Fig. 1D-F). Difference be-
tween locations of AC measured in 1.5 T and 7.0 T image sets 
was 1.1 +/- 0.1 mm and PC was 1.1 +/- 0.2 mm. Maximum devi-
ation was 1.3 mm. In the co-registered images of the 7.0 T MRI 
and 1.5 T MRI, total four metastastic brain tumors were found; 
three lesions in the left parietal and temporal lobe, and one in 
the right side of the pons (Fig. 2). In the co-registered images of 
1.5 T (Fig. 2A-D) and 7.0 T MRI (Fig. 2E-H), there was no discrep-
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Fig. 3. Axial, coronal, and sagittal images of a metastatic lesion in the left parietal lobe in the co-registered images of 1.5 T and 7.0 T magnetic resonance images (MRI). The 
tumor is demarcated in blue line and its 50%-isodose volume of 22 Gy is marked with yellow line in the left parietal lobe in the axial, coronal, and sagittal view of the co-
registered images of 1.5 T (A-C) and 7.0 T MRI (D-F). Paek SH, et al.  •  7.0 T MRI in GK Radiosurgery
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ancy of the position of four metastatic lesions between the 1.5T 
and 7.0T MRI whereas enhanced anatomical details of the met-
astatic brain tumors were provided by 7.0 T MRI. There was no 
significant discrepancy of the tumor volume (blue line) and its 
50%-isodose volume of 22 Gy (yellow line) in the left parietal 
lobe (a lesion of Fig. 2A) between 1.5 T (upper panel) and 7.0 T 
MRI (lower panel), which were plotted in the axial, coronal, and 
sagittal view of the co-registered images (Fig. 3). The volume of 
the tumor measured in 1.5 T and 7.0 T MRI were 0.096 cm
3 and 
0.088 cm
3, respectively. Among the four metastatic lesions, two 
lesions which were of volume 0.096 cm
3 and 0.079 cm
3, respec-
tively, were included in volume comparison because the other 
two were too small (< 0.03 cm
3). Volume of the bigger tumor mea-
sured in 1.5 T images were 0.096 cm
3 and 0.088 cm
3 in 7.0 T im-
ages, respectively. The difference was larger than standard devi-
ation of volume measurement in each set (0.003 cm
3). The small-
er one was measured as 0.079 cm
3 in 1.5 T and 0.078 cm
3 in 7.0 
T, and difference was smaller than standard deviation of mea-
surement (0.004 cm
3).
  Co-registered sagittal images of the third tumor (a lesion shown 
in Fig. 2C) (Fig. 4A, C) and coronal images of the fourth tumor 
(a lesion shown in Fig. 2D) (Fig. 4B, D) are demonstrated in Fig. 
4. While only high signal intensity regions in 1.5 T MRI (Fig. 4A, 
B), blood vessels connected to the tumors are clearly identified 
in high resolution images of 7.0 T MRI (Fig. 4C, D). Enhanced 
anatomical details of the metastatic brain tumors were provid-
ed by 7.0 T MR images. In 7.0 T MR images, we could clearly see 
blood vessels connected to the lesion whereas only high signal 
intensity regions are identified in 1.5 T MR images. 
DISCUSSION
We have demonstrated in this case that gadolinium-enhancing 
7.0 T MR images were safely taken in a patient with mestastatic 
brain tumors to provide high resolution imaging. In the past, 
there were anecdoctal reports of high field MR images of 7.0 T 
or higher performed in a small group of normal subjects or pa-
tients (1, 3-10). Thomas et al. (9) described the in vivo 7.0 T MR 
images of higher signal-to-noise and novel contrast to provide 
enhanced scrutiny of hippocampal anatomy with their microve-
nous structures in six normal subjects Kollia et al. (5) compared 
the 7.0 T MR images with conventional 1.5 T MR images in twelve 
consecutive patients with clinically definite multiple sclerosis. 
They have reported that ultra-high-field imaging of patients with 
multiple sclerosis at 7.0 T MR images was well tolerated and pro-
vided better visualization of multiple sclerosis lesions in the gray 
matter. However, there is no report about the use of 7.0 T MR 
images for brain tumors yet and only animal brain tumor model 
Fig. 4. Sagittal and coronal images 
of metastatic lesions (arrow) in the 
left temporal lobe and the right 
side of the pons in the co-regis-
tered images of 1.5 T and 7.0 T 
magnetic resonance images (MRI). 
While only high signal intensity 
regions in 1.5 T MRI (A, B), blood 
vessels connected to the tumors 
are clearly identified in high resolu-
tion images of 7.0 T MRI (C, D). 
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is reported because of the technical and safety issues (2, 11, 12). 
Cha et al. (11) evaluated the growth and vascularity of implant-
ed GL261 mouse gliomas by using 7.0 T MR images with con-
ventional T1- and T2-weighted imaging and dynamic, contrast-
enhanced T2-weighted imaging in 34 C57BL6 mice at different 
stages of tumor development. 
  To our knowledge, this is the first report in that the gadolini-
um-enhanced 7.0 T MR images were safely taken in the patients 
with metastatic brain tumors and detailed distortion effect was 
documented in comparison with low field MR images. After au-
tomatic co-registration procedures, the discrepancy of the loca-
tion of AC and PC between two image sets was within 1.5 mm. 
The discrepancies were combined effects of image distortion 
and image co-registration. Errors along the cranio-caudal direc-
tion were larger than the other two perpendicular directions. 
The fact that slice thickness of 1.5 T axial images was more than 
twice thicker than that of 7.0 T images may explain the larger 
errors in this direction. Geometric distortion due to static field 
and local susceptibility effects has been a major concern in high-
field MR images (4). Despite these technical issues, we found 
that the co-registered 7.0 T MR images have only a little discrep-
ancy in the positions of the physiological landmarks such as AC 
and PC as well as the locations of four metastatic brain tumors 
from 1.5 T MR images. We think this is an important finding for 
the future users of ultra-high field MR images for radiosurgery 
of brain tumors. 
  Recent studies reported that the 3D MPRAGE shows the su-
perior performance, such as contrast and sensitivity, in the brain 
tumor imaging compared to others (13, 14). Our study demon-
strated that the contrast enhanced T1-weighted imaging at high 
field 7.0 T MR images, using 3D MP RAGE sequence can be safe-
ly used for GK radiosurgery of metastatic brain tumors. It is ex-
pected that the superior signal to noise ratio (SNR) of the 7.0 T 
MR images than the lower field MRI can provide the higher sen-
sitivity and resolution in the brain tumor imaging. We also dem-
onstrated in this case that 7.0 T MR images taken a day before 
Gamma Knife radiosurgery can be safely utilized in targeting 
and the dosiplanning for the treatment of metastatic brain tu-
mors with the fusion of 1.5 T MR images taken in the patient 
with the Leksell frame on the day of Gamma Knife radiosurgery 
by using the image fusion program, ImageMerge
TM (Elekta AB, 
Stockholm, Sweden) integrated in the GammaPlan
® v8.3 of Per-
fexion
® (Elekta AB, Stockholm, Sweden).
  In conclusion, our study demonstrates that ultra-high-field 
imaging of the metastatic brain tumors at 7.0 T using 3D MP 
RAGE sequence is well tolerated with reasonable scanning time 
and little image distortion, which provides better visualization 
of anatomical details than 1.5 T. We believe that combination of 
higher signal-to-noise ratio of 7.0 T MR images and more accu-
rate geometrical characteristics of 1.5 T MRI can provide better 
results for GK RS of brain metastases.
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